Control groups are as follows: (1) MR mice with normal water in which MGF remains repressed (controls for non-specific effects of the transgenic background)
FDA-approved therapeutic peptides have undergone extensive clinical trials with documented safety profiles
Martemucci G, Costagliola C, Mariano M, Dandrea L, Napolitano P, DAlessandro AG
Unpacking the science behind the findings The reason for the decrease in GLP-1 effective from stopping and starting may lie in body composition, according to the researchers
This condition is characterised by impaired glucose disposal and increased hepatic glucose production, as well as disruptions in sex hormone regulation
In either case, researchers are paying significantly more than the actual cost of the compound plus independent testing